Hey, mooers! Welcome back to Moomoo's Feature Challenge, where we help you master powerful tools on moomoo and take on quiz challenges to win rewards!
Every company's financials tell a unique story, revealing important information about its revenue, assets, liabilities, and cash flow.
By analyzing this data, investors can gain valuable insights into a company's performance and make informed decisions about where to put th...

$LumiraDx (LMDXF.US)$ I do not believe our shares will be harmed in this deal. Bear case is Roche is going to screw Lumiradx investors. That is far from the truth. Seems likely Tobias/Paul/or Neil will step in as CEO hand picked by Roche. Furthermore there is no indication that Roche will take the Razor in this deal. Katalyst diagnostics uses the Lumira platform. So yes while Roche will technically own the company I believe Lumiradx will remain it's own entity like ACIU and others. Roche will ge...